Atlas Trials

Study Testing the Biologic Activity and Safety of an Immunotherapeutic in Patients With Newly Diagnosed Stage IV Kidney Cancer

Clinical trial NCT00272649 · COMPLETED

Trial details

NCT number
NCT00272649
Sponsor
Argos Therapeutics
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Renal Cell Carcinoma
Start date
2006-01-01
Primary completion
2012-02-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.